Page last updated: 2024-10-30

metformin and Chronic Lung Injury

metformin has been researched along with Chronic Lung Injury in 4 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"The pandemic of coronavirus disease 2019 (COVID-19), a disease which causes severe lung injury and multiple organ damage, presents an urgent need for new drugs."2.66Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury. ( Chen, X; Deng, Q; Guo, H; Leng, Q; Qiu, L; Zhang, C, 2020)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Ahmadvand, MH1
Nikzad, S1
Changizi, V1
Pashaki, AS1
Najafi, M1
Mirzaei, F1
Gao, J1
Yuan, J1
Wang, Q1
Lei, T1
Shen, X1
Cui, B1
Zhang, F1
Ding, W1
Lu, Z1
Chen, X1
Guo, H1
Qiu, L1
Zhang, C1
Deng, Q1
Leng, Q1
Yu, LL1
Zhu, M1
Huang, Y1
Zhao, YM1
Wen, JJ1
Yang, XJ1
Wu, P1

Reviews

1 review available for metformin and Chronic Lung Injury

ArticleYear
Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatmen

2020

Other Studies

3 other studies available for metformin and Chronic Lung Injury

ArticleYear
Evaluation of the Mitigation Effect of Spirulina Against Lung Injury Induced by Radiation in Rats.
    Current radiopharmaceuticals, 2023, Volume: 16, Issue:1

    Topics: Animals; Antioxidants; Lung Injury; Male; Metformin; Radiopharmaceuticals; Rats; Rats, Wistar; Spiru

2023
Metformin protects against PM
    Redox biology, 2020, Volume: 28

    Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Biopsy; Cell Line; Disease Models, Animal; Disea

2020
Metformin relieves acute respiratory distress syndrome by reducing miR-138 expression.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:16

    Topics: Animals; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Lipopolysaccharides; Lung

2018